A recent study discovered that HSF1 enhances prostate cancer cell resistance to ferroptosis by modulating HSPE1, and that HSF1 knockdown can promote prostate cancer cell sensitivity to RSL3 therapy (91). The gene discussed is HSPE1; the disease is Familial prostate cancer.